Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Clinical Trial Comparing Treatment With Cloxacillin Versus Benzylpenicillin in Bacteraemia Caused by Penicillin-susceptible Staphylococcus Aureus (PSSA)

NCT06726395 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06726395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06726395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Clinical Trial Comparing Treatment With Cloxacillin Versus Benzylpenicillin in Bacteraemia Caused by Penicillin-susceptible Staphylococcus Aureus (PSSA)
Lead sponsor
Region Skane
Phase
Phase 4
Overall status
Recruiting
Start date
March 10, 2025
Completion date
July 31, 2028
Enrollment
420 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcal bacteraemia, staphylococcus (s.) aureus infection, staphylococcus aureus bacteraemia, staphylococcus aureus bloodstream infections (bsi; bacteremia)